Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Bucillamine in Treatment of Patients With COVID-19

ClinicalTrials.gov ID: NCT04504734

Public ClinicalTrials.gov record NCT04504734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Bucillamine in Patients With Mild-Moderate COVID-19

Study identification

NCT ID
NCT04504734
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Revive Therapeutics, Ltd.
Industry
Enrollment
713 participants

Conditions and interventions

Conditions

Interventions

  • Bucillamine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 26, 2020
Primary completion
Jun 11, 2023
Completion
Jun 11, 2023
Last update posted
Jul 6, 2023

2020 – 2023

United States locations

U.S. sites
46
U.S. states
15
U.S. cities
41
Facility City State ZIP Site status
Cullman Clinical Trials Cullman Alabama 35055
Avant Research Associates, LLC Huntsville Alabama 35802
West Valley Research Clinic Phoenix Arizona 85031
HealthStar Research LLC Hot Springs Arkansas 71913
ASCADA Research Huntington Beach California 92648
Samuel Ross MD Inc. Los Angeles California 90035
Amicis Research Center Northridge California 91324
Optimus Medical Group San Francisco California 94102
C & R Research Services USA Coral Gables Florida 33134
Sweet Hope Research Specialty Inc Hialeah Florida 33016
Encore Medical Research Hollywood Florida 33021
Entrust Clinical Research Kendall Florida 33156
Columbus Clinical Services Miami Florida 33125
Verus Clinical Research Miami Florida 33125
Nuren Medical & Research Center Miami Florida 33144
Advance Medical Research Services Corp Miami Florida 33165
Amavita Clinical Research North Miami Beach Florida 33169
C & R Research Services USA Tampa Florida 33614
Encore Medical Research of Weston LLC Weston Florida 33321
Clinical Site Partners LLC Winter Park Florida 32789
American Clinical Trials LLC Acworth Georgia 30101
Quad Clinical Research LLC Chicago Illinois 60643
Koch Family Medicine Morton Illinois 61550
Revive Research Institute Inc. Farmington Hills Michigan 48334
SRI International Plymouth Michigan 48170
Great Lakes Research Institute Southfield Michigan 48075
Revival Research Institute LLC Sterling Michigan 48312
Machuca Family Medicine Las Vegas Nevada 89104
Prime Global Research The Bronx New York 10456
OnSite Clinical Solutions Charlotte North Carolina 28208
OnSite Clinical Solutions, LLC Charlotte North Carolina 28277
Monroe Biomedical Research Monroe North Carolina 28112
Superior Clinical Research Smithfield North Carolina 27577
Superior Clinical Research Yanceyville North Carolina 27379
Dayton Clinical Research Dayton Ohio 45406
Pharmacorp Clinical Trials Inc. Charleston South Carolina 29412
Novaceut Clinical Research Clarksville Tennessee 37043
Physicians Quality Care Jackson Tennessee 38305
Inquest Clinical Research Baytown Texas 77521
C & R Research Services USA Houston Texas 77022
Encore Imaging and Medical Research Houston Texas 77065
R & H Clinical Research Inc. Katy Texas 77494
FMC Science Lampasas Texas 76550
Family Practice Center McAllen Texas 78501
R & H Clinical Research Inc. Stafford Texas 77477
Renovatio Clinical The Woodlands Texas 77380

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04504734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04504734 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →